Yuhan Subsidiary Waijeumedi Obtains GMP Certification for Second Jincheon Plant
"Aggressive Sales Based on Expanded CAPA"
Waijeumedi, an intravenous solution specialist and a subsidiary of Yuhan Corporation, announced on the 23rd that it has received Good Manufacturing Practice (GMP) compliance certification for pharmaceuticals from the Ministry of Food and Drug Safety for its second plant in Jincheon.
The second plant, located in Jincheon-gun, North Chungcheong Province, includes a dedicated aseptic injectable (intravenous solution) production line equipped with the latest facilities. Based on the expanded production capacity (CAPA) secured through this GMP certification, the company plans to pursue aggressive sales activities to increase its market share both domestically and overseas.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Waijeumedi representative said, "The GMP certification of the second plant is significant in that it certifies our quality competitiveness at a global level," adding, "We will ensure a stable supply of high-quality pharmaceuticals based on our strengthened production capacity."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.